Wang Yan, Xue Wei-cheng, Si Lu, Cui Chuan-liang, Lu Ai-ping, Cao Deng-feng, Guo Jun, Li Zhong-wu
Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, China.
Zhonghua Bing Li Xue Za Zhi. 2013 Mar;42(3):178-81. doi: 10.3760/cma.j.issn.0529-5807.2013.03.008.
To investigate the correlations among Ki-67 expression, mitosis and other clinicopathological parameters of primary cutaneous malignant melanoma, and search for prognostic factors of malignant melanoma.
Totally 127 cases of primary cutaneous malignant melanoma were collected from Beijing Cancer Hospital. Immunohistochemical study for Ki-67 was performed, and the mitosis was calculated referring to "hot spot" method recommended by the seventh edition of the American Joint Committee on Cancer (AJCC) melanoma staging system. The correlations of Ki-67 expression, mitosis and other clinicopathological parameters were analyzed, and the survival analysis of all these risk factors including TNM and Clark level was conducted based on follow up data.
The expression level of Ki-67 was associated with necrosis and Breslow thickness (P < 0.05). Mitosis was correlated with Clark level and Ki-67 expression (P < 0.05). Univariate analysis indicated Ki-67 expression level (P = 0.043), mitosis (P = 0.030) and TNM stage (P < 0.001) might influence the survival of patients. However, multivariate analysis showed that the TNM staging was the only independent prognostic factor affecting survival.
The prognosis of patients with primary cutaneous malignant melanoma was closely related to the TNM staging at the fist examination. Ki-67 expression and mitosis are two important clinicopathological parameters of primary cutaneous malignant melanoma.
探讨原发性皮肤恶性黑色素瘤中Ki-67表达、有丝分裂与其他临床病理参数之间的相关性,寻找恶性黑色素瘤的预后因素。
收集北京肿瘤医院127例原发性皮肤恶性黑色素瘤病例。进行Ki-67免疫组织化学研究,并参照美国癌症联合委员会(AJCC)黑色素瘤分期系统第七版推荐的“热点”方法计算有丝分裂数。分析Ki-67表达、有丝分裂与其他临床病理参数的相关性,并根据随访数据对包括TNM和Clark分级在内的所有这些危险因素进行生存分析。
Ki-67表达水平与坏死及Breslow厚度相关(P<0.05)。有丝分裂与Clark分级及Ki-67表达相关(P<0.05)。单因素分析表明,Ki-67表达水平(P=0.043)、有丝分裂(P=0.030)和TNM分期(P<0.001)可能影响患者生存。然而,多因素分析显示,TNM分期是影响生存的唯一独立预后因素。
原发性皮肤恶性黑色素瘤患者的预后与首次检查时的TNM分期密切相关。Ki-67表达和有丝分裂是原发性皮肤恶性黑色素瘤的两个重要临床病理参数。